secwatch.observer — SEC 8-K summary
======================================

Issuer:     AIxCrypto Holdings, Inc. (AIXC)
CIK:        0001460702
Form:       8-K
Filed at:   2024-07-15T23:59:59+00:00
Accession:  0001493152-24-027879
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 4.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Qualigen Therapeutics dismisses Baker Tilly, appoints Withum as new auditor
---------------------------------------------------------------------------

- Dismissed Baker Tilly US, LLP effective July 11, 2024; engaged WithumSmith+Brown, PC as successor.
- Baker Tilly's reports for FY 2022 and 2023 included a going concern explanatory paragraph.
- No disagreements with Baker Tilly; a material weakness was communicated to the audit committee.
- Company authorized Baker Tilly to respond fully to Withum's inquiries regarding the material weakness.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1460702/000149315224027879/0001493152-24-027879-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1460702/000149315224027879/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-027879

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer